Differential Regional and Subtype-Specific Vulnerability of Enteric Neurons to Mitochondrial Dysfunction by Viader, Andreu et al.
Differential Regional and Subtype-Specific Vulnerability
of Enteric Neurons to Mitochondrial Dysfunction
Andreu Viader
1., Elizabeth C. Wright-Jin
2., Bhupinder P. S. Vohra
1,3, Robert O. Heuckeroth
2, Jeffrey
Milbrandt
1*
1Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2Department of Pediatrics and Department of
Developmental, Regenerative and Stem Cell Biology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3Department of Biology,
University of Central Arkansas, Conway, Arkansas, United States of America
Abstract
Mitochondrial dysfunction is a central mediator of disease progression in diverse neurodegenerative diseases that often
present with prominent gastrointestinal abnormalities. Gastrointestinal dysfunction in these disorders is related, at least in
part, to defects in the enteric nervous system (ENS). The role of mitochondrial deficits in ENS neurodegeneration and their
relative contribution to gastrointestinal dysfunction, however, are unclear. To better understand how mitochondrial
abnormalities in the ENS influence enteric neurodegeneration and affect intestinal function, we generated mice (Tfam-
ENSKOs) with impaired mitochondrial metabolism in enteric neurons and glia through the targeted deletion of the
mitochondrial transcription factor A gene (Tfam). Tfam-ENSKO mice were initially viable but, at an early age, they developed
severe gastrointestinal motility problems characterized by intestinal pseudo-obstruction resulting in premature death. This
gastrointestinal dysfunction was caused by extensive, progressive neurodegeneration of the ENS involving both neurons
and glia. Interestingly, mitochondrial defects differentially affected specific subpopulations of enteric neurons and regions
of the gastrointestinal tract. Mitochondrial deficiency-related neuronal and glial loss was most prominent in the proximal
small intestine, but the first affected neurons, nitrergic inhibitory neurons, had the greatest losses in the distal small
intestine. This regional and subtype-specific variability in susceptibility to mitochondrial defects resulted in an imbalance of
inhibitory and excitatory neurons that likely accounts for the observed phenotype in Tfam-ENSKO mice. Mitochondrial
dysfunction, therefore, is likely to be an important driving force of neurodegeneration in the ENS and contribute to
gastrointestinal symptoms in people with neurodegenerative disorders.
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Introduction
Gastrointestinal dysfunction is a prevalent symptom in neuro-
logic and systemic diseases associated with neurodegeneration.
Constipation, for example, is the most widely recognized non-
motor symptom in people with Parkinson’s disease (PD), the
second most common neurodegenerative disorder in industrialized
countries [1,2]. Decreased frequency of bowel movements is in fact
one of the earliest signs of PD, predating the development of the
classic motor symptoms, sometimes by many years [3–5]. In
addition, impaired gastric emptying is estimated to affect the
majority of patients with PD and complicates treatment by
interfering with levodopa absorption, which can only be absorbed
once it reaches the small intestine (SI) [1,6,7]. Similarly, up to 75%
people with diabetes mellitus, a systemic metabolic disease
associated with progressive neuronal damage [8], experience a
variety of gastrointestinal symptoms ranging from diarrhea to
severe gastroparesis and constipation [9]. Gastrointestinal dys-
function in these neurodegenerative disorders is related, at least in
part, to abnormalities and cell loss in the enteric nervous system
(ENS) [9–11], the complex network of neurons and glia that
innervates the gut and controls intestinal function. A better
understanding of the pathophysiology of neurodegeneration within
the ENS could therefore be relevant to the treatment of patients
with diseases characterized by neuron loss with prominent
gastrointestinal symptoms.
Mitochondria are now thought to be critical mediators of
disease progression in diverse disorders such as PD and diabetes.
Studies primarily focusing on the central nervous system (CNS)
have established that mitochondrial dysfunction is involved in both
the initiation and propagation of disease processes that eventually
result in neuron death [12,13]. A growing body of evidence
indicates that mitochondrial defects may similarly contribute to
neurodegeneration in the ENS. Consistent with this notion, rodent
models of PD induced by mitochondrial toxins are characterized
by ENS pathology and cell loss, even at doses below those
necessary to cause CNS pathology [14–17]. Indeed, the ENS
appears to be particularly susceptible to mitochondrial dysfunction
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primary inherited mitochondrial disorders, a heterogeneous group
of complex multisystem diseases, commonly include gastrointes-
tinal symptoms. As is the case in PD, symptoms of gastrointestinal
dysfunction can precede other presentations of mitochondrial
deficits and, in some cases (e.g. mitochondrial neurogastrointest-
inal encephalomyopathy, or MNGIE) may be the most prominent
manifestation of the disease [18]. The role of mitochondrial
abnormalities in ENS neurodegeneration and its relative contri-
bution to gastrointestinal dysfunction, however, remain poorly
understood.
With the goal of elucidating how mitochondrial abnormalities in
the ENS contribute to enteric neurodegeneration and affect
gastrointestinal function, we generated mice with impaired
mitochondrial metabolism in neurons and glia of the ENS. These
Tfam-ENSKO mice were generated by tissue-specific deletion of
the gene encoding mitochondrial transcription factor A (Tfam),
which is required for mitochondrial DNA (mtDNA) transcription
and replication [19]. We show that normal mitochondrial function
in the ENS is essential for the survival of both enteric neurons and
glia as well as for maintenance of normal gastrointestinal motility.
Interestingly, we found that mitochondrial dysfunction differen-
tially affected specific subpopulations of enteric neurons and, most
surprisingly, specific regions of the gastrointestinal tract. Mito-
chondrial deficiency-related neuronal and glial loss was most
prominent in the proximal SI, but nitrergic, inhibitory neurons
were less severely affected in this region and, instead, were most
affected in the distal SI. This regional and subtype variability of
enteric neurons appears to directly correlate to the phenotype
observed in Tfam-ENSKO mice, with dilation in the proximal SI
and relative constriction in the distal SI. Mitochondrial dysfunc-
tion in the ENS and the regional- and subtype-specific
vulnerabilities of enteric neurons are likely contributors to the
gastrointestinal symptoms of patients suffering from some
neurodegenerative disorders.
Results
Cre-mediated deletion of Tfam results in mitochondrial
abnormalities in the ENS
To study how mitochondrial dysfunction in the ENS affects
gastrointestinal function and contributes to enteric neurodegener-
ation, we generated mice with disrupted mitochondrial metabo-
lism in both enteric neurons and glia (Tfam-ENSKOs). For this
purpose we used a previously developed mouse with loxP-flanked
Tfam alleles (Tfam
loxP) [19]. Tfam is a mitochondrial protein
encoded by nuclear DNA that is essential for mtDNA mainte-
nance, copy number regulation and transcription [19,20].
Previous studies have shown that cre-mediated deletion of Tfam
in Tfam
loxP homozygous mice results in severe tissue-specific
mtDNA depletion and mitochondrial respiratory chain deficiency
[19,21–25]. The tissue-specific deletion of Tfam is, therefore, an
effective way to induce mitochondrial dysfunction in a selected
population of cells.
We mated Tfam
loxP mice to mice expressing cre-recombinase
under the control of the Cnp promoter (CNP-Cre) [26]. Cnp
encodes the enzyme 29,3 9-cyclic nucleotide 39-phosphodiesterase
(CNP), a commonly used marker for myelin-forming glia.
However, we inadvertently discovered that the Cnp promoter also
drives the expression of cre-recombinase in the ENS and thereby
induces recombination in the majority of enteric neurons and glia.
Consistent with this fortuitous observation, CNP has been
reported to be highly expressed in gut neural crest stem cells
[27]. Indeed, when we crossed CNP-Cre mice with Cre-inducible
Rosa26-YFP reporter animals, YFP fluorescence was visible in
over 90% of enteric neurons and glia throughout the gut (Fig. 1a
and b).
Crossing of Tfam-ENSKO mice to Cre-inducible Rosa26-YFP
reporter animals (YFP/Tfam-ENSKOs) showed that Tfam was
efficiently excised in all enteric neurons and glia in which we
observed Cnp-mediated expression of cre-recombinase (as visual-
ized by YFP fluorescence). When we isolated YFP-positive enteric
neurons and glia from 7 week old YFP/Tfam-ENSKO mice, we
could not detect the Tfam allele by RT-PCR analysis (Fig. 1c).
Given the extent and high efficiency of the Cnp promoter-driven
expression of cre-recombinase, we conclude that the mating of
Tfam
loxP to CNP-Cre mice resulted in animals that lacked Tfam in
the majority of enteric neurons and glia.
To determine the functional effect of deleting Tfam in the ENS,
we next assessed mtDNA copy number in YFP-positive enteric
neurons and glia from 7 week old YFP/Tfam-ENSKO and YFP/
control mice. Tfam has an essential role in the maintenance and
replication of mtDNA [19,20] and previous reports have described
severe mtDNA depletion following tissue-specific excision of Tfam
from a cell of interest [19,21–25]. Consistent with this, we found
an 80% reduction in total mtDNA content in enteric neurons and
glia isolated from different regions throughout the gut of YFP/
Tfam-ENSKO mice (Fig. 1d).
In previous studies using Tfam
loxP mice, the depletion of mtDNA
following Tfam excision has been shown to induce severe
respiratory chain deficiency, since the mitochondrial genome
encodes 13 subunits that are essential components of the electron
transport chain. In addition, Tfam deficiency-induced mitochon-
drial dysfunction is accompanied by abnormalities in mitochon-
drial morphology [19,21–25,28]. Therefore, to further confirm the
enteric neuron- and glia-specific disruption of mitochondria in
Tfam-ENSKO mice we examined the enteric nervous system by
electron microscopy. Abundant abnormal and enlarged mito-
chondria with distorted cristae were found specifically within
enteric neurons and glia of Tfam-ENSKOs but not of control
littermates (Fig. 1e). Together, our results confirm that by deleting
Tfam in enteric neurons and glia we were able to generate mice
with disrupted mitochondria in the ENS.
Tfam-ENSKOs develop progressive gastrointestinal
dysfunction characterized by intestinal pseudo-
obstruction
Tfam-ENSKO mice were viable and born at the expected
Mendelian ratios and, for the first 2 weeks of life, they were
indistinguishable from their control littermates. After 2 weeks of
age, however, Tfam-ENSKO mice displayed signs of poor growth
and, by 4 weeks of age, they were significantly smaller than their
control littermates (Fig. 2a). In addition, Tfam-ENSKO mice
developed abdominal distention at about 6-8 weeks of age, which,
together with poor growth, suggests gastrointestinal dysfunction.
After 8 weeks of age, the health of Tfam-ENSKO mice
deteriorated rapidly and the majority of the animals died by 12
weeks of age (Fig. 2b).
Dissection of late stage (i.e. 10–12 weeks old) Tfam-ENSKO
mice consistently revealed massive dilation within the proximal
small bowel along with relative contraction of the distal small
bowel (Fig. 2c). The region of transition from dilated proximal
small bowel to the narrower distal small bowel was consistently
located within the mid-small bowel, with variable accumulation
of luminal contents in the proximal small bowel and stomach.
No stenosis or mechanical cause of the obstruction could be
found and the mice did not have malrotation or other anatomic
explanations for the obstruction. Proximal to the transition
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colored luminal contents and the bowel wall appeared to be
stretched thinner than in controls (Fig. 2c). Luminal contents
were absent distally and no stool pellets could be found in the
colon or rectum. The distal small intestine and colon in Tfam-
ENSKOs generally appeared to have a smaller diameter than in
control mice. Therefore, we conclude that disrupted mitochon-
drial metabolism in enteric neurons and glia in Tfam-ENSKO
mice results in significant gastrointestinal dysfunction and
dysmotility.
Figure 1. CNP-Cre excises Tfam in enteric neurons and glia and disrupts ENS mitochondria in Tfam-ENSKO mice. a) YFP fluorescence
in 2-day-old Rosa26-YFP/CNP-Cre mice overlaps (merge) with enteric neurons (HuC/HuD
+ cells, Hu, red) and glia (Sox-10
+ cells, Sox, blue). Excision-
dependent YFP fluorescence is visible in the majority of enteric neurons and glia in all gut regions. Asterisks indicate the occasional non-recombined,
non-YFP
+ cell. Scale bars: 30 mm. b) Quantification of the percent of YFP
+ neurons (% of HuC/HuD
+ and YFP
+ cells/total HuC/HuD
+ cells) and glia (% of
Sox-10
+ and YFP
+ cells/total Sox-10
+ cells) in different gut regions confirms high efficiency of CNP-Cre mediated recombination in the ENS. n=3 mice
per genotype. c) RT-PCR of Tfam transcript demonstrates the complete excision of Tfam in YFP
+ FACS selected myenteric neurons and glia in YFP/
Tfam-ENSKO mice at 7 weeks of age. n=3 mice per genotype. d) qRT-PCR results show depletion of mtDNA content in YFP
+ FACS-selected myenteric
neurons and glia in 7 week old YFP/Tfam-ENSKO mice. mtDNA content was significantly reduced in YFP/Tfam-ENSKO mice in all regions examined at
this age (*, p,0.01). Reported values are normalized to nuclear DNA content and ratio of mtDNA to nuclear DNA in control animals was set at 100;
n=3 mice per genotype. e) Electron micrographs of myenteric plexus mitochondria (arrowheads) in 7 week old control and Tfam-ENSKO mice. Tfam-
ENSKO myenteric neurons and glia contain abundant abnormal, enlarged mitochondria with dilated and distorted cristae. Scale bars, 500 nm.
doi:10.1371/journal.pone.0027727.g001
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degeneration with distinct regional vulnerabilities
To test the hypothesis that ENS defects underlie the bowel
abnormalities and early death observed in Tfam-ENSKO mice,
we used whole mount immunohistochemical methods to evaluate
ENS structure. We initially examined total myenteric neuron
density using immunohistochemistry for HuC/HuD, a widely used
pan-neuronal marker that labels the cell body of all neurons within
the myenteric plexus [29]. Two week old Tfam-ENSKO mice had
a lower mean neuron density in all regions examined compared to
control animals, but these differences were not statistically
significant (p.0.1 in all cases, Fig. 3b and Table 1). This suggests
that the ENS develops normally in these animals and is consistent
with the healthy appearance of Tfam-ENSKOs at this age.
We next examined the myenteric plexus of 7 week old Tfam-
ENSKO and control mice. At this age, Tfam-ENSKO mice begin
to show subtle phenotypic abnormalities (i.e. poor growth) but
appear healthy, do not display signs of gastrointestinal obstruction,
and lack intestinal dilation (Fig. 2a and b). Despite their healthy
appearance, at 7 weeks of age Tfam-ENSKO mice had a 68%
decrease in myenteric neuron density in the proximal SI, and a
41% decrease in the distal SI (Fig. 3a and b and Table 1).
Surprisingly, even though the extent of Tfam excision appeared
equal in all regions analyzed at 7 weeks of age (Fig. 1), we found no
difference in colon total neuron density between Tfam-ENSKOs
and control littermates at this age (Fig. 3a and b and Table 1). In
fact, enteric neuron density in the colon of Tfam-ENSKOs
remained normal even at late pathological stages (e.g. 10-12 weeks
old), when enteric neurodegeneration in more proximal regions
was profound (data not shown). Thus, mitochondrial dysfunction
in the ENS results in progressive neurodegeneration with marked
differences in regional vulnerability to neuronal loss.
Glial degeneration parallels that of neurons in Tfam-
ENSKOs
A growing body of literature now implicates glial dysfunction in
many neurodegenerative diseases traditionally thought to be
neuron autonomous. In animal models of amyotrophic lateral
sclerosis, PD, and Huntington’s disease among others, glia-specific
abnormalities alter disease onset and progression (for a review see
Figure 2. Tfam-ENSKOs develop progressive GI dysfunction characterized by intestinal pseudo-obstruction. a) Growth curve of Tfam-
ENSKO mice and control littermates. Tfam-ENSKOs are initially indistinguishable from control mice, but begin to exhibit poor growth at 4 weeks of
age (n$10 mice per genotype at each time point). b) Survival curve of Tfam-ENSKO mice and control littermates. Tfam-ENSKO mice die prematurely
beginning at 60 days old. By 90 days, nearly all Tfam-ENSKO mice are dead. n=47 mice. c) Photograph of gastrointestinal tract of 11-12 week old
control and Tfam-ENSKO mice depicts their typical appearance. Arrowheads indicate regions of dilation and accumulation of luminal contents. St:
stomach, SI: small intestine, Co: colon.
doi:10.1371/journal.pone.0027727.g002
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related gastrointestinal dysfunction of Tfam-ENSKO mice, we
assessed the effect of Tfam-depletion on enteric glia using Sox-10
immunohistochemistry. We first examined glial density in the
myenteric plexus of 2 week old mice and observed very little
difference between Tfam-ENSKOs and littermate controls except
in the distal SI (Fig. 3c and Table 1). By 7 weeks of age, however,
Tfam-ENSKO mice had significantly reduced glial cell density in
both the proximal and distal SI (Fig. 3a and 3c and Table 1).
However, as is the case for HuC/HuD
+ neurons, the glial cell
density in the colon of Tfam-ENSKO mice remained normal at 7
weeks of age (Fig. 3a and 3c and Table 1).
The changes in glial cell density in Tfam-ENSKO mice,
therefore, seemed to parallel that of neurons, involving the same
Figure 3. Tfam-ENSKO mice display progressive degeneration of neurons and glia with distinct regional vulnerabilities.
a) Representative images of HuC/HuD (neurons, red) and Sox-10 (glia, green) immunohistochemistry in three regions of myenteric plexus of 7 week
old control and Tfam-ENSKO mice. Loss of both HuC/HuD
+ neurons and Sox-10
+ glia is apparent in Tfam-ENSKOs at this age. Scale bars, 100 mm.
b) Quantification of total myenteric neuron density in Tfam-ENSKOs expressed relative to control littermates at 2 and 7 weeks of age. For 2 weeks old,
n=6 (Ctrl) and n=4 (Tfam-ENSKO). For 7 weeks old, n=3 for each genotype. c) Quantification of glial density in Tfam-ENSKOs expressed relative to
control littermates at 2 and 7 weeks of age. For 2 weeks old, n=6 (Ctrl) and n=4 (Tfam-ENSKO). For 7 weeks old, n=3 for each genotype. d) Neuron-
to-glia ratio in ENS of Tfam-ENSKOs and control littermates at 2 and 7 weeks of age demonstrates that relative cell loss is equivalent for both neurons
and glia. For 2 weeks old, n=6 (Ctrl) and n=4 (Tfam-ENSKO). For 7 weeks old, n=3 for each genotype. PSI: proximal small intestine, DSI: distal small
intestine, Co: colon.
doi:10.1371/journal.pone.0027727.g003
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detail by comparing the ratio of neurons to glia in control and
Tfam-ENSKOmice.Asexpectedfromtheabsenceofeitherneuron
or glial cell loss in 2 week old Tfam-ENSKOs, we found no
difference in the neuron to glia ratio in any of the regions examined
compared to control animals (Fig. 3d and Table 1). Interestingly,
despiteextensiveneuron and glia loss in7weekoldTfam-ENSKOs,
the ratio of neurons to glia in all regions examined remained
comparable to that of control littermates (Fig. 3d and Table 1).
These results suggest that enteric neurons and glia are equally
susceptible to mitochondrial defects in Tfam-ENSKO mice.
Early and differential loss of nitrergic inhibitory neurons
in Tfam-ENSKO mice
Intestinal motility and peristalsis depend on the balance
between ENS excitatory and inhibitory inputs which together
produce the rhythmic coordination of contraction and relaxation
necessary to propel luminal contents [31]. The apparent
constriction observed in the distal bowel of Tfam-ENSKO mice,
as well as the dilation proximal to this point (Fig. 2c), suggested the
possibility of an imbalance between these inputs. To address how
enteric neuron loss in Tfam-ENSKO mice affects the balance
between inhibitory and excitatory inputs, we examined the
number and proportion of nitric oxide (NO)-producing inhibitory
neurons in the myenteric plexus by NADPH diaphorase
(NADPH-d) staining [32]. The proportion of NADPH-d
+ neurons
in different gut regions is normally within a narrow range that
maintains the balance between ENS excitatory and inhibitory
inputs and allows for normal intestinal motility. As early as 2 weeks
of age, the NADPH-d
+ neuron density in the proximal and distal
SI in Tfam-ENSKO mice was significantly lower than in controls
(Fig. 4b and Table 1). These data suggest early preferential loss of
nitrergic inhibitory neurons relative to other neuronal subtypes.
As the pathologic changes in the ENS of Tfam-ENSKO mice
progressed, the loss of NADPH-d
+ neurons became more
pronounced and, moreover, by 7 weeks of age the percentage of
NADPH-d
+ neurons varied quite dramatically between different
regions of the gut. NADPH-d
+ neuron loss was greatest in the
distal SI with a 60% decrease, but significant decreases were also
found in the proximal SI and colon (33% and 25%, respectively;
Fig. 4a and b and Table 1). Interestingly, the observed loss of
nitrergic neurons did not parallel the loss of total neurons in each
region (Fig. 3a and b), causing significant differences in the relative
proportion of NADPH-d
+ neurons to total neurons (i.e. changes in
inhibitory input) throughout the bowel (Fig. 4c and Table 1). In 7
week old Tfam-ENSKOs, NADPH-d
+ neurons accounted for
75% of total neurons in the proximal SI compared to 36% in
controls (Fig. 4c and Table 1). In contrast, in the distal SI, the
proportion of NADPH-d
+ inhibitory neurons was lower than in
control animals, (19% in Tfam-ENSKOs, 28% in controls; Fig. 4c
and Table 1). In the colon, there was no significant difference in
the ratio of nitrergic to total neurons between control and Tfam-
ENSKO mice (Fig. 4c and Table 1). This concurrent increase in
relative abundance of inhibitory inputs in the proximal SI along
with the decrease in the ratio of NADPH-d
+ to total neurons in the
distal SI of Tfam-ENSKOs may thus account for the proximal
dilation and distal constriction observed in the late pathology of
these mice (Fig. 4d).
Axonal degeneration is a key feature of enteric neuron
loss in Tfam-ENSKOs and may precede cell body loss
During our examination of NADPH-d
+ neurons, we observed
extensive and prominent blebbing in neuronal projections in the
T
a
b
l
e
1
.
M
y
e
n
t
e
r
i
c
P
l
e
x
u
s
C
e
l
l
D
e
n
s
i
t
y
.
T
o
t
a
l
n
e
u
r
o
n
d
e
n
s
i
t
y
(
C
e
l
l
s
/
m
m
2
)
G
l
i
a
l
c
e
l
l
d
e
n
s
i
t
y
(
C
e
l
l
s
/
m
m
2
)
N
e
u
r
o
n
-
t
o
-
G
l
i
a
R
a
t
i
o
(
N
e
u
r
o
n
s
/
G
l
i
a
)
N
A
D
P
H
-
d
+
N
e
u
r
o
n
D
e
n
s
i
t
y
(
C
e
l
l
s
/
m
m
2
)
%
o
f
t
o
t
a
l
n
e
u
r
o
n
s
t
h
a
t
a
r
e
N
A
D
P
H
-
d
+
R
e
g
i
o
n
A
g
e
(
w
e
e
k
s
)
C
t
r
l
T
f
a
m
-
E
N
S
K
O
%
o
f
C
t
r
l
p
v
a
l
u
e
C
t
r
l
T
f
a
m
-
E
N
S
K
O
%
o
f
C
t
r
l
p
v
a
l
u
e
C
t
r
l
T
f
a
m
-
E
N
S
K
O
%
o
f
C
t
r
l
p
v
a
l
u
e
C
t
r
l
T
f
a
m
-
E
N
S
K
O
%
o
f
C
t
r
l
p
v
a
l
u
e
C
t
r
l
T
f
a
m
-
E
N
S
K
O
%
o
f
C
t
r
l
p
v
a
l
u
e
P
S
I
2
1
2
2
1
6
1
5
6
8
3
9
6
1
4
8
0
.
1
3
3
2
3
1
6
6
1
2
6
1
8
3
1
6
2
1
6
0
.
0
7
1
0
.
5
4
6
0
.
0
9
0
.
4
9
6
0
.
1
2
0
.
7
0
6
3
0
3
6
2
4
1
8
8
6
2
6
6
2
%
0
.
0
3
0
2
5
2
2
N
/
A
D
S
I
2
2
3
5
5
6
3
8
1
1
7
4
7
6
4
6
1
0
.
3
3
9
3
1
4
2
6
2
3
9
2
0
9
4
6
1
7
6
6
7
%
0
.
0
1
2
0
.
7
7
6
0
.
1
4
0
.
8
3
6
0
.
1
8
0
.
7
9
4
5
7
4
6
2
8
3
5
0
6
4
6
6
1
%
0
.
0
1
4
2
4
2
0
N
/
A
C
o
2
2
1
1
3
6
2
8
6
1
8
7
9
6
3
1
7
0
.
6
0
7
3
6
3
3
6
3
7
2
3
1
1
7
6
2
6
8
0
.
3
4
3
0
.
6
1
6
0
.
1
1
0
.
6
0
6
0
.
0
8
0
.
9
6
1
5
7
8
6
7
3
5
5
7
6
9
3
0
.
8
6
0
2
7
3
0
N
/
A
P
S
I
7
2
3
5
6
2
3
7
4
6
5
3
1
%
0
.
0
0
3
4
7
9
6
3
1
2
5
0
6
3
1
5
2
%
0
.
0
0
7
0
.
4
9
6
0
.
0
2
0
.
3
2
6
0
.
0
6
0
.
0
5
4
8
2
6
6
5
5
6
4
6
7
%
0
.
0
2
1
3
6
6
5
7
5
6
1
2
2
0
8
%
0
.
0
3
8
D
S
I
7
3
2
9
6
1
8
1
9
4
6
1
4
5
9
%
0
.
0
0
4
7
4
4
6
5
5
5
1
5
6
3
8
6
9
%
0
.
0
2
7
0
.
4
5
6
0
.
0
3
0
.
3
8
6
0
.
0
4
0
.
4
0
0
9
1
6
9
3
6
6
5
4
0
%
0
.
0
0
7
2
8
6
2
1
9
6
2
6
8
%
0
.
0
3
5
C
o
7
5
4
8
6
8
5
4
2
6
6
3
3
0
.
2
5
8
1
4
0
9
6
4
8
1
1
5
3
6
8
7
0
.
0
6
2
0
.
3
7
6
0
.
0
6
0
.
3
5
6
0
.
0
6
0
.
7
8
2
1
4
7
6
8
1
1
0
6
7
7
5
%
0
.
0
2
7
2
1
6
4
2
6
6
1
0
.
2
8
8
M
y
e
n
t
e
r
i
c
p
l
e
x
u
s
n
e
u
r
o
n
a
n
d
g
l
i
a
l
c
e
l
l
d
e
n
s
i
t
y
a
n
d
r
a
t
i
o
s
i
n
2
a
n
d
7
-
w
e
e
k
-
o
l
d
T
f
a
m
-
E
N
S
K
O
a
n
d
c
o
n
t
r
o
l
m
i
c
e
.
n
=
3
f
o
r
e
a
c
h
g
e
n
o
t
y
p
e
f
o
r
a
l
l
a
n
a
l
y
s
e
s
o
f
7
w
e
e
k
o
l
d
m
i
c
e
.
F
o
r
2
w
e
e
k
o
l
d
m
i
c
e
,
n
=
6
(
C
t
r
l
)
o
r
4
(
T
f
a
m
-
E
N
S
K
O
)
f
o
r
t
o
t
a
l
n
e
u
r
o
n
d
e
n
s
i
t
y
,
g
l
i
a
l
d
e
n
s
i
t
y
,
a
n
d
n
e
u
r
o
n
t
o
g
l
i
a
r
a
t
i
o
a
n
d
n
=
3
f
o
r
N
A
D
P
H
-
d
+
n
e
u
r
o
n
d
e
n
s
i
t
y
.
N
/
A
,
n
o
t
a
p
p
l
i
c
a
b
l
e
;
d
u
e
t
o
s
m
a
l
l
s
i
z
e
o
f
t
i
s
s
u
e
s
a
m
p
l
e
s
a
t
2
w
e
e
k
s
o
f
a
g
e
,
s
t
a
i
n
i
n
g
f
o
r
b
o
t
h
H
u
C
/
H
u
D
+
(
t
o
t
a
l
)
a
n
d
N
A
D
P
H
-
d
+
(
n
i
t
r
e
r
g
i
c
)
c
o
u
l
d
n
o
t
b
e
p
e
r
f
o
r
m
e
d
o
n
a
s
i
n
g
l
e
a
n
i
m
a
l
a
n
d
t
h
e
r
e
f
o
r
e
s
t
a
t
i
s
t
i
c
a
l
a
n
a
l
y
s
i
s
o
f
t
h
e
p
r
o
p
o
r
t
i
o
n
o
f
t
o
t
a
l
n
e
u
r
o
n
s
t
h
a
t
a
r
e
N
A
D
P
H
-
d
+
w
a
s
n
o
t
p
o
s
s
i
b
l
e
.
P
S
I
:
p
r
o
x
i
m
a
l
s
m
a
l
l
i
n
t
e
s
t
i
n
e
,
D
S
I
:
d
i
s
t
a
l
s
m
a
l
l
i
n
t
e
s
t
i
n
e
,
C
o
:
c
o
l
o
n
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
2
7
7
2
7
.
t
0
0
1
Mitochondria-Induced Enteric Neurodegeneration
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27727Figure 4. Early and differential loss of nitrergic inhibitory neurons in Tfam-ENSKO mice. a) Representative images of NADPH-d stained
myenteric plexus show inhibitory neurons in the proximal SI and distal SI in 7 week old Tfam-ENSKO mice. Scale bar, 150 mm. b) Quantitative analysis
of NADPH-d
+ neuron density in Tfam-ENSKOs relative to control littermates at 2 and 7 weeks of age. n=3 for each genotype at each age. c) Ratio of
nitrergic neurons to total neurons in 7 week old Tfam-ENSKO and control mice. n=3 for each genotype. PSI: proximal small intestine, DSI: distal small
intestine, Co: colon. d) Diagram depicting how the imbalance of inhibitory neurons to excitatory neurons in each region in Tfam-ENSKOs could
produce the observed proximal SI dilation and distal SI constriction. In Tfam-ENSKO mice, greater total neuron loss (Tfam-ENSKO top panel) relative to
NADPH-d
+ neuron loss (Tfam- ENSKO middle panel) would result in increased inhibitory input and dilation of the proximal SI (Tfam-ENSKO bottom
panel). Greater NADPH-d
+ neuron loss (Tfam-ENSKO middle panel) relative to total neuron loss (Tfam-ENSKO top panel) would result in decreased
inhibitory input and constriction (and pseudoobstruction) of the distal SI of Tfam-ENSKO mice (bottom panel). Color intensity represents neuronal
density with WT density set as the most intense color in all regions of the bowel.
doi:10.1371/journal.pone.0027727.g004
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PNS, axon blebbing has been recognized as a sign of axonal
degeneration, a central component of many neurodegenerative
diseases, which can precede and sometimes cause neuronal death
[33]. To assess the role of axon degeneration in the neuron loss
observed in Tfam-ENSKOs we first examined the neuronal
projections, or neurites, extending into the villi in the proximal
and distal SI. As early as two weeks of age, Tfam-ENSKO mice
displayed signs of neurite loss within intestinal villi, although at this
age neurite degeneration was limited to the proximal SI (Fig. 5c
and Table 2). Neurite loss worsened over time, and by 7 weeks of
age the number of neurites in the villi of Tfam-ENSKO mice was
significantly reduced in both the proximal and distal SI (Fig. 5b
and c and Table 2) suggesting that loss of neuronal projections
could contribute to subsequent neuron loss.
Because we are unable to easily identify the cell of origin for
neurites in the villi, we also quantified neuronal fiber density for
NADPH-d
+ fibers in the myenteric plexus of 7 week old mice. We
found no difference in the density of large fiber bundles (i.e.,
primary fibers; [34]) in any region examined between Tfam-
ENSKOs and controls (Table 3). In contrast, small fiber density
(i.e., secondary and tertiary fibers; [34]) was significantly lower
(44%) in the proximal SI of Tfam-ENSKOs mice, but was similar
to controls in the distal SI and colon (Table 3). Note, however, that
what we count as ‘‘small fibers’’ or ‘‘large fiber bundles’’ are
actually one or more tightly fasciculated neurites. In Tfam-
Figure 5. Axonal degeneration is present in Tfam-ENSKO mice and may precede enteric neuron loss. a) Tfam-ENSKO mice show
noticeable neurite blebbing (arrowheads) in the proximal and distal SI at 7 weeks of age. Scale bars, 25 mm. b, c) Representative images (b) and
quantification (c) of TuJ1
+ neurites extending into SI villi of 7 week old control and Tfam-ENSKO mice. n=3 for each genotype. Scale bars, 40 mm.
d, e) Representative images (d) and quantification (e) of axonal fragmentation (TuJ1, green) and cell body loss (ethidium homodimer, staining not
shown) in cultured enteric neurons after treatment with the mitochondrial inhibitors rotenone or antimycin. Images correspond to untreated or
rotenone-treated enteric neurons. n= duplicate wells for each condition from 3 independent assays. Scale bars, 100 mm.
doi:10.1371/journal.pone.0027727.g005
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appear significantly thinner than in control animals at 7 weeks of
age (Fig. 4a and 5a), suggesting that our counting method for
NADPH-d+ neuronal projections significantly underestimates
neurite loss in the mutant mice. Because of these limitations, we
devised an alternate method to evaluate the effect of mitochondrial
dysfunction on enteric neuron and neurite degeneration in vitro.
E12.5 enteric neurons were cultured from control mouse gut
and exposed to different inhibitors of the mitochondrial electron
transport chain (e.g. rotenone and antimycin). Disrupting
mitochondrial respiration induced significant neurite degeneration
within 24 hours, yet did not initially affect neuron viability as
measured by ethidium homodimer staining (Fig. 5d and e and
Table 4). Moreover, even though extended exposure to mito-
chondrial inhibitors eventually induced enteric neuron death, the
proportion of cells showing axonal degeneration remained larger
at every time point examined (Table 4). Together, these results
suggest that axonal degeneration precedes enteric neuron cell
body loss induced by mitochondrial defects.
Discussion
The current understanding of how mitochondrial deficits affect
enteric neurons and contribute to ENS neurodegeneration and
gastrointestinal dysfunction has been hindered by a lack of animal
models. Here we describe a new mouse model with disrupted
mitochondrial function in enteric neurons and glia. We show that
abnormal mitochondrial metabolism in the ENS causes wide-
spread enteric neurodegeneration and results in severe intestinal
pseudo-obstruction, the likely cause of premature death in Tfam-
ENSKO mice. Remarkably, mitochondrial dysfunction differen-
tially affected specific subpopulations of enteric neurons and
regions of the gastrointestinal tract. This regional and subtype-
specific variability resulted in an imbalance of inhibitory and
excitatory enteric neurons that likely accounts for the observed
phenotype in Tfam-ENSKO mice. Our observations support the
hypothesis that damage to the ENS resulting from defects in
mitochondrial function may underlie some of the pathophysiology
involved in gastrointestinal abnormalities in many human
neurodegenerative diseases.
Mitochondria are thought to be critical mediators of neuron loss
in diverse neurodegenerative disorders such as PD or diabetes. We
show that mitochondrial defects in the ENS cause both neuron
and glia cell loss as well as severe intestinal dysmotility. Strikingly,
not all regions of the gut were equally affected. The proximal SI
suffered the most extensive neuron and glial loss whereas the colon
was largely spared (Fig. 3). Furthermore, we observed differential
vulnerability among distinct subtypes of enteric neurons. Nitrergic
neurons, which are predominantly inhibitory in nature, were lost
earliest in the progression of the disease in Tfam-ENSKOs (Fig. 4).
These findings cannot be explained by variations in the efficiency
of Tfam excision or in the resulting effect on mitochondria. Cnp-
mediated expression of cre-recombinase (as visualized by YFP
fluorescence) and mtDNA depletion were comparable throughout
the bowel of Tfam-ENSKO mice (Fig. 1). The observed variability
in sensitivity to mitochondrial defects suggests, therefore, that
there are regional and cell type specific differences in metabolic
needs for individual enteric neuron populations.
In the CNS, regional- and subtype-specific differences in the
vulnerability of neurons to mitochondrial dysfunction are well
established; such differences are thought to underlie the preferen-
tial loss of striatal neurons in PD or Huntington’s disease [35].
Early preferential loss of nitrergic neurons has also been reported
in a streptozotocin-induced rat model of diabetic autonomic
neuropathy [36]. Similar differences in vulnerability to metabolic
insults among enteric neurons had been suggested by an earlier
study using a rotenone-induced rat model of PD [16]. The enteric
nervous system abnormalities observed in Tfam-ENSKO mice
suggest that regional- and subtype-specific differences in the
susceptibility of neurons to mitochondrial defects are also present
in the ENS and may explain the gastrointestinal presentations of
neurodegenerative diseases.
While the mitochondrial dysfunction in Tfam-ENSKO mice is
caused by the loss of Tfam, the way in which these mice
recapitulate gastrointestinal pathological features often seen in
neurodegenerative disorders indicates that there may be broader
implications of this work for understanding the bowel dysfunction
that accompanies both rare and common human disease. For
example, Tfam-ENSKO mice consistently developed intestinal
pseudo-obstruction with dilated proximal small bowel and
contracted distal bowel reminiscent of that seen in the human
mitochondrial disease MNGIE. Our results indicate that this
Table 2. Villus Neurite Density.
Neurites/villus
Region Age (weeks) Ctrl Tfam-ENSKO % of Ctrl p value
PSI 2 4.2560.18 2.7260.09 64% 0.002
DSI 2 3.6360.25 3.1860.2 0.235
PSI 7 1061.3 2.660.23 26% 0.006
DSI 7 1261.6 4.160.35 34% 0.011
Density of neuronal projections in intestinal villi in 2 and 7 week old Tfam-
ENSKO and control mice. n=3 for each genotype and age. PSI: proximal small
intestine, DSI: distal small intestine, Co: colon.
doi:10.1371/journal.pone.0027727.t002
Table 3. Nitrergic Fiber Density.
NADPH-d
+ Bundles/mm
2 NADPH-d
+ Fibers/mm
2 NADPH-d
+ Fibers/neuron
Region
Age
(weeks) Ctrl
Tfam-
ENSKO
%o f
Ctrl
p
value Ctrl
Tfam-
ENSKO
%o f
Ctrl
p
value Ctrl
Tfam-
ENSKO
%o f
Ctrl
p
value
PSI 7 1960.5 1462 0.073 312618 174632 56% 0.020 3.960.6 3.160.5 0.208
DSI 7 22631 9 60.5 0.700 298625 23366 0.100 3.461.4 6.864.8 0.098
Co 7 25612 5 61 0.844 583656 52765 0.378 4.060.7 4.860.2 0.099
Myenteric NADPH-d
+ fiber density and number of NADPH-d
+ fibers per neuron in 7 week old Tfam-ENSKO and control mice. n=3 for each genotype. PSI: proximal small
intestine, DSI: distal small intestine, Co: colon.
doi:10.1371/journal.pone.0027727.t003
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ratio of inhibitory to excitatory inputs in the ENS. In Tfam-
ENSKOs such an imbalance arises from a relative preservation of
nitrergic inhibitory neurons in the proximal SI and preferential
loss of these same neurons in the distal SI of these mice. This is of
particular interest, because the severe intestinal pseudo-obstruc-
tion resulting in cachexia and death in MNGIE patients has
traditionally been attributed to smooth muscle abnormalities, even
though mtDNA depletion is also found within enteric neurons in
the SI of MNGIE patients [37]. Our results demonstrating that
mitochondrial dysfunction in enteric neurons and glia alone is
capable of producing very similar pathology, however, suggest that
the ENS may play a more prominent role in this mitochondrial
disease than previously thought.
While MNGIE is a rare disease, mitochondrial dysfunction is
thought to be a common underlying mechanism in both normal
human aging [38] as well as in many common diseases such as
type 2 diabetes [39]. Defects in gastrointestinal motility frequently
cause serious problems in the elderly and in patients with diabetes
[9,40]. These motility defects, similar to what we observed in
Tfam-ENSKO mice, have been attributed to enteric neurodegen-
eration [9,40]. Moreover, enteric neurodegeneration in models of
aging, PD and diabetes have been associated with imbalances in
inhibitory and excitatory neurons [40]. As such, understanding the
ENS abnormalities in Tfam-ENSKO mice could provide valuable
insight into the pathophysiology responsible for gastrointestinal
motility disorders involved in numerous disease processes and
affecting a large number of people.
In summary, Tfam-ENSKO mice are the first genetic model of
enteric nervous system-specific mitochondrial dysfunction and
interestingly recapitulate a number of pathological features often
seen in human neurodegenerative diseases with prominent
gastrointestinal presentations, such as MNGIE, PD or diabetes
mellitus. Enteric mitochondrial dysfunction in these diseases is
therefore likely to contribute to their gastrointestinal pathology.
Moreover, Tfam-ENSKOs revealed a remarkable region- and
subtype-specific differential vulnerability of enteric neurons to
defects in mitochondrial metabolism. Appropriate management of
gastrointestinal dysfunction in patients with neurodegenerative
diseases might thus be facilitated by devising therapeutic strategies
that improve ENS mitochondrial function and address the
differential vulnerability of specific enteric neuron populations.
Materials and Methods
Ethics
All studies were reviewed and approved by the Washington
University Animal Studies Committee, protocol approval #
20110071 (J.M.) and # 20090190 (ROH).
Matings of transgenic animals
Tfam
loxP/loxP mice [19] and CNP-Cre mice [26] in pure C57Bl/
6 backgrounds were crossed to generate Tfam-ENSKO mice
(CNP-Cre
+/-, Tfam
loxP/loxP) and their control littermates (CNP-Cre
-/-,
Tfam
loxP/loxP or CNP-Cre
-/-, Tfam
+/loxP). For experiments involving
YFP fluorescence-based FACS sorting or imaging of enteric
neurons and glia, Tfam-ENSKO mice were crossed to Rosa26-
YFP reporter mice [41] to generate YFP/Tfam-ENSKO mice
(Rosa26-YFP
+/-, CNP-Cre
+/-, Tfam
loxP/loxP). Mice with transgenic
Rosa26-YFP and CNP-Cre alleles, but with wild type Tfam alleles
(YFP/control: Rosa26-YFP
+/-, CNP-Cre
+/-, Tfam
+/+), were used as
controls in these experiments. Tfam
loxP/loxP, CNP-Cre and
Rosa26-YFP genotyping were carried out as previously described
[19,26,41].
Quantitative ENS analysis
Mice were euthanized by carbon dioxide asphyxiation followed
by cervical dislocation. The gastrointestinal tract was removed and
enteric whole-mount samples were prepared. Intestines were
flushed with ice cold PBS, then opened by cutting along the
mesenteric border, flattened and pinned mucosal side down, and
fixed using 4% paraformaldehyde for 30 minutes. After fixation,
samples were washed with ice cold PBS before isolating the
myenteric plexus by peeling off the muscle layers of the intestine. A
6 cm-long intestinal sample was isolated from the proximal SI
(measured from the pylorus), distal SI (measured from the ileocecal
junction), and distal colon (measured from the anus). In the 2-
week-old mice, 3–4 cm long samples were obtained from the same
regions as described above. Samples were then cut into 1 to 2 cm
segments before storing in 50% glycerol/PBS at 220uC until
staining and analysis.
In the 7-week-old mice, sequential 1 cm-long samples of
myenteric plexus were stained with NADPH-d [42], biotinylated-
HuC/HuD (1:250; Invitrogen A21272) and Sox-10 (1:250; Santa
Cruz). In the 2-week-old mice, sequential 1-1.5 cm long samples of
myenteric plexus were stained with NADPH-d or biotinylated-
HuC/HuD and Sox-10, again using the order described above.
For the biotinylated-HuC/HuD and Sox-10 double labeling,
samples were first labeled by HuC/HuD immunohistochemistry
(1:250; Invitrogen A21272) and then labeled by Sox-10 immuno-
histochemistry (1:250; Santa Cruz).
Quantification of neuron or glial cell density was done by
counting all cells present within the borders of a 0.560.5 mm grid
(20x objective lens). For instances in which the cellular density was
very high, counts were done using a 40x objective lens (within the
borders of a 0.2560.25 mm grid). An attempt was made to stretch
all segments evenly and equally for all samples. All analyses used
three to six animals, and counting was done without knowledge of
the mouse genotype. Twenty (20) randomly selected fields were
Table 4. In vitro Mitochondrial Inhibitor Assay Results.
Neurons with fragmented
axons (%/well) % of Control p value
Et2D
+ (dead)
Neurons (%/well) % of Control p value
Time Veh Rot Antim Rot Antim Rot Antim Veh Rot Antim Rot Antim Rot Antim
24 hrs 7.361.2 26.3631 5 63.6 360% 205% 0.004 0.03 5.760.3 861.15 6.361.5 0.124 0.5
48 hrs 6.761.2 51.766.7 1261 772% 179% 0.003 0.01 6.760.3 3163.6 1262.6 463% 179% 0.002 0.01
72 hrs 7.761.2 83.764.7 3266.8 1087% 416% ,0.001 0.003 760.6 58.765.2 19.363.2 839% 276% ,0.001 0.003
In vitro mitochondrial inhibitor assay results from cultured E12.5 immunoselected enteric neurons. n= duplicate wells for each condition from 3 independent assays.
Veh=Vehicle; Rot=Rotenone; Antim=Antimycin
doi:10.1371/journal.pone.0027727.t004
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2.
Averages for each animal were used to calculate the mean,
standard deviation and standard error for each genotype. Neuron-
to-glia ratio was determined by dividing the number of neurons by
the number of glia present within a single field.
Villus neurite quantification
Villus preparations were made by cutting along single rows of
intestinal villi from full-thickness, pinned samples of proximal and
distal small intestine in 70% ethanol. These were then labeled by
TuJ1 (1:10,000; Covance) immunohistochemistry. Villus neurite
quantification was determined by counting all TuJ1
+ projections
that crossed a perpendicular line drawn through the middle of
each villus. Twenty (20) randomly selected villi were counted for
each region and averaged for each animal. At least 3 mice were
used to calculate the mean, standard deviation and standard error
for each genotype.
FACS isolation of enteric neurons and glia
Rosa26-YFP
+ cells were sorted by flow cytometry after isolating
and digesting unfixed myenteric plexus from 7-week-old YFP/
control and YFP/Tfam-ENSKO mice. A modified version of the
protocol published by Schafer et al. [43] was used to isolate adult
mouse ENS neurons and glia. Briefly, muscle layers of the bowel
containing the myenteric plexus were isolated by dissection as
described above, but were not fixed. Samples from the proximal
SI, distal SI and colon were cut into 1 mm
2 pieces in ice-cold PBS,
then treated with collagenase (1 mg/ml in DMEM; 37uC, 45 min).
After collagenase treatment, tissues were centrifuged at 4,500 rpm
for 2 min and collagenase solution was replaced with 0.25%
Trypsin in DMEM. Samples were rotated (37uC, 20–30 min) and
triturated by pipetting before centrifugation (4,500 rpm for 2 min)
to remove supernatant. Cells were diluted in 300 mL FACS buffer
(0.002% BSA, 0.001% Sodium Azide, 1 mM EDTA in PBS) and
filtered through 70 micron MACS separation filters. Cells were
then sorted for YFP expression on a MoFlo Cell Sorter (Beckman
Coulter Corp., Fullerton, CA), using 15 p.s.i. and a 120 mm
sorting nozzle. YFP fluorescence was captured with a 525/40
optical filter in the cytometer’s FL 1 channel. Samples were taken
from three mice of each genotype (YFP/Ctrl: Rosa26-YFP
+/-, CNP-
Cre
+/-, Tfam
+/+; YFP/Tfam-ENSKO: Rosa26-YFP
+/-, CNP-Cre
+/-,
Tfam
loxP/loxP) and a non-YFP
+ littermate (Rosa26-YFP
-/-, CNP-
Cre
+/-, Tfam
+/+ or Rosa26-YFP
-/-, CNP-Cre
+/-, Tfam
loxP/loxP) was
used for standardization.
RNA and DNA preparation and quantitative real-time PCR
(qRT-PCR)
RNA and DNA were isolated from FACS sorted enteric
neurons and glia from YFP/Tfam-ENSKO mice and YFP/Ctrl
littermates. For RNA isolation, cells were lysed in Trizol reagent
(Invitrogen) and total RNA prepared according to the manufac-
turer’s protocol. For DNA isolation, cells were digested and DNA
isolated using DNeasy Blood and Tissue Kit (Qiagen) according to
the manufacturer’s protocol. DNA and RNA concentration were
quantified using an ND-1000 spectrophotometer (Nanodrop
Technologies).
For RT-PCR, cDNA was reverse transcribed from total RNA
using M-MLV reverse transcriptase (Invitrogen) and Tfam or
GAPDH mRNA were amplified using the following primers (59-
39): Tfam: F, CAGGAGGCAAAGGATGATTC; R, ATGTC-
TCCGGATCGTTTCAC; GAPDH: F, TGCCCCCATGTT-
TGTGATG; R, TGTGGTCATGAGCCCTTCC. mtDNA con-
tent was quantified by qRT-PCR using a SYBR green-based
detection system on a 7700 Sequence Detector instrument
(Applied Biosystems) as described previously [44]. Instead of
cDNA, however, 15 ng of total DNA were used per reaction.
Primers that recognize a region unique to the mitochondrial
genome were used to determine mtDNA content normalized to
nuclear DNA content, as determined by a set of primers directed
to the genomic locus of Smrt1. The primers used were as follows:
mtDNA: F, AAGTCGTAACAAGGTAAGCA; R, ATATTT-
GTGTAGGGCTAGGG. Nuc.DNA: F, GGGTATATTTTT-
GATACCTTCAATGAGTTA; R, TCTGAAACAGTAGGTA-
GAGACCAAAGC
Cell culture
Enteric neural crest cells were immunoselected from embryonic
day 12.5 (E12.5) CD1 mice small bowel and colon using p75
NTR
antibody (Millipore). Bowel was dissociated with collagenase (1
mg/ml) and dispase (1 mg/ml) to yield a single cell suspension.
After p75
NTR antibody incubation (Millipore, 1:1000, 1 h, 4uC) in
B27 (Invitrogen) supplemented Neurobasal medium, cells were
incubated with goat anti-rabbit coupled paramagnetic beads (1:50,
1h ,4 uC; Miltenyi Biotec, Bergisch Gladbach, Germany) before
separating neural crest-derived cells from unselected cells with a
positive selection column (MACS separation columns; Miltenyi
Biotec). Immunoselected crest-derived cells were plated at a
density of 500 cells per well on poly-d-lysine/laminin-coated 24-
well plates in B27 supplemented Neurobasal medium plus 50 ng/
ml glial cell line-derived neurotrophic factor (GDNF). In all
experiments, inhibitors were added to the medium 24 h after
plating using 2.5 mm antimycin (Complex III inhibitor) or 2.5 mm
rotenone (Complex I inhibitor). Control wells were treated with
DMSO vehicle. All experiments were performed in triplicate. All
analyses were performed blinded.
Neuronal cell body death assay and
Immunohistochemistry
Neurons were treated with inhibitors or vehicle control and
monitored for cell body damage by ethidium homodimer
exclusion (Biotium, Hayward, CA). Ethidium homodimer was
added to the cultures at a final concentration of 100 nM and after
30 minutes of incubation cells were washed with PBS and fixed
4% paraformaldehyde. After fixation, cells were washed with PBS
and blocked with 5% normal donkey serum in TBST (Tris-
buffered saline plus 0.1% Triton X-100) (1 h, 37uC). Cells were
incubated in rabbit polyclonal Tuj1 antibody (1:1000 at 4uC
overnight) and antibody binding was visualized with Alexa Fluor
488 conjugated anti-rabbit secondary antibodies (Jackson Im-
munoresearch Laboratory, 1:500, 25uC, 1 h).
Electron Microscopy
Samples for transmission electron microscopy were obtained
from 7 week old mice by intracardiac perfusion of Modified
Karnovsky’s Fixative (2.5% glutaraldehyde, 2% paraformaldehyde
in 0.1 mmol/liter cacodylate buffer), followed by isolation of
whole mount samples as described above, omitting peeling. Gut
samples were pinned in modified Karnovsky’s Fixative and post-
fixed in 2% OsO4 (in 0.1 mmol/L cacodylate buffer). Samples
were then dehydrated and embedded in PolyBed 812 (Polysciences
Inc., Warrington, PA). 100 nm sections were cut with a Diatome
diamond knife and stained with uranyl acetate in 50% methanol
and Venable’s lead citrate. Transmission EM was performed on a
JEOL JEM 1200-EX microscope with AMT Advantage HR
(Advanced Microscopy Techniques Corp., Danvers MA) high-
speed, wide-angle 1.3 megapixel TEM digital camera.
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Samples were counted using a 10610 grid counting eyepiece on
an Olympus Optical Bx60 microscope or Zeiss Axioskop and an
Axiocam digital camera and AxioVision imaging software (Zeiss,
Germany). Photoshop 7.0 was used to uniformly adjust contrast
and brightness so that digital images appear as they did when
observed directly through the microscope.
Statistical analysis
All values are expressed as mean 6 SEM. P values were
determined by paired Student’s t-test or Mann-Whitney rank sum
test using Sigma Plot 11.0 (Systat Software, San Jose, CA). In all
applicable figures, an asterisk (*) indicates statistical significance
(p value , 0.05).
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